| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 |
| Total Expenses - EUR | 122 | 20 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 |
| Gross Profit/Loss - EUR | -122 | -20 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 |
| Net Profit/Loss - EUR | -122 | -20 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 |
Check the financial reports for the company - Isomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 12.508 | 12.360 | 12.151 | 11.928 | 11.697 | 11.475 | 11.221 | - | 11.221 | 11.159 |
| Current Assets | 177 | 175 | 173 | 169 | 166 | 163 | 159 | - | 159 | 158 |
| Inventories | 162 | 160 | 158 | 155 | 152 | 149 | 146 | - | 146 | 145 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 |
| Cash | 15 | 15 | 15 | 15 | 14 | 14 | 14 | - | 14 | 14 |
| Shareholders Funds | -34.901 | -34.565 | -33.980 | -33.356 | -32.710 | -32.090 | -31.379 | - | -31.381 | -31.205 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | - | 40 | 40 |
| Debts | 54.796 | 54.237 | 53.319 | 52.341 | 51.327 | 50.354 | 49.237 | - | 49.240 | 48.965 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
5221
|
|||||||||
Comments - Isomed Srl